Discover Glo 2021– Discover Bioluminescent Tools and Luciferase Technologies
Now Available On-Demand
生物発光ツールの可能性と、標的タンパク質分解やキナーゼバイオロジーなどの重要な治療分野での理解を深めるためにこれらのツールがどのように応用されているかをご紹介します。
ルシフェラーゼ技術をご利用の方の研究と貢献を讃える1週間です !
この30年の間に、生物発光という自然現象を利用したアッセイやテクノロジーは、目新しい研究ツールから、現在では研究ツールボックスの基盤の1つへと変化しました。生物発光を利用した革新的なアプローチは、ライフサイエンスや創薬の研究者が利用できる有用な実験手法あるいは科学的進歩への貢献の両面で広がりを見せています。このウェビナーシリーズでは、業界の専門家とプロメガの科学者が、キナーゼ、GPCR、標的タンパク質分解などの重要な研究トピックの最新情報を紹介します。また、これらのテーマに限らず、他の創薬ターゲットや研究分野に応用可能な最新の技術についてもご紹介します。
Bill Linton
President and CEO of Promega Corporation
Opening Remarks
Illuminating your Innovations - 30 Years and Glo-ing
Speakers
Director, Research-Advanced Technologies
Promega Corporation
Presentation: Teaching an Old Dog New Tricks: New Applications for Bioluminescence
Neurobiologist and PhD Student
Biodonostia Sanitary Research Institute (Basque Country, Spain)
Presentation: Discovery of a Novel Family of FKBP12 “Reshapers” and Their Use As Calcium Modulators in Skeletal Muscle Under Nitro-Oxidative Stress
Director, Biomedical Innovation
The University of Western Australia and MTPConnect WA Life Sciences Innovation Hub
Presentation: Profiling of GPCR Complexes
Assistant Professor
Tokyo Medical and Dental University
Presentation: Endogenous Protein Analysis Using Genome Editing Technology and HiBiT System
Senior Research Scientist
Promega Corporation
Presentation: Exploring the Scalability of HiBiT Knock-In Tagging
COO, SGC-Frankfurt Director of Operations of the Chemical Probes Portal
Presentation: Are You On Target? Probing Target Engagement.
Teamleader cellular assays, SGC Frankfurt
Presentation: Are You On Target? Probing Target Engagement
Senior Research Scientist
Promega Corporation
Presentation: Quantifying the Impact of Intracellular Kinase Complexes On Target Engagement with NanoBRET
R&D Group Leader, Functional Proteomics
Promega Corporation
Presentation: Understand Cellular Mechanisms of Targeted Protein Degradation
Professor of Chemical and Structural Biology
University of Dundee, School of Life Sciences
Presentation Targeted Protein Degraders: An Overview
Agenda
Bioluminescence: Past, Present, Future
Illuminating Your Innovations - 30 Years and Glo-ing
Bill Linton – Chief Executive, Promega
Teaching an Old Dog New Tricks: New Applications for Bioluminescence
Thomas Machleidt, PhD – Director, Research-Advanced Technologies, Promega
Discovery of a Novel Family of FKBP12 “Reshapers” and Their Use As Calcium Modulators in Skeletal Muscle Under Nitro-Oxidative Stress
Pablo Marco-Moreno – Neurobiologist and PhD Student, Biodonostia Sanitary Research Institute (Basque Country, Spain)
Applications of CRISPR Knock-In Tagging for Studying Endogenous Protein Dynamics
Profiling of GPCR Complexes
Professor Kevin Pfleger MA, PhD – Director, Biomedical Innovation, The University of Western Australia and MTPConnect WA Life Sciences Innovation Hub
Endogenous Protein Analysis Using Genome Editing Technology and HiBiT System
Takahide Matsushima, PhD – Assistant Professor, Tokyo Medical and Dental University
Exploring the Scalability of HiBiT Knock-In Tagging
Christopher Eggers, PhD – Senior Research Scientist, Promega
Understanding Kinase Target Engagement in Live Cells
Are You On Target? Probing Target Engagement
Dr. Susanne Müller-Knapp – COO, SGC-Frankfurt Director of Operations of the Chemical Probes Portal
Dr. Benedict-Tilman Berger – Teamleader cellular assays, SGC Frankfurt
Quantifying the Impact of Intracellular Kinase Complexes on Target Engagement with NanoBRET
Matt Robers – Senior Research Scientist, Promega
Advances in Targeted Protein Degradation
Targeted Protein Degraders: An Overview
Alessio Cuilli, PhD – Professor of Chemical and Structural Biology, University of Dundee, School of Life Sciences
Understand Cellular Mechanisms of Targeted Protein Degradation
Danette Daniels, PhD – R&D Group Leader, Functional Proteomics, Promega
Try GloMax Instruments In Your Lab
